Recent data suggests that retatrutide, a dual-action medication, might represent a significant step in weight reduction . This drug combines the effects of a GLP-1 receptor and a GIP analog, potentially offering a greater outcome than current approaches . Clinical assessments have revealed promising findings , including considerable reductions in w